NCT04462419View on ClinicalTrials.gov

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

TerminatedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

December 13, 2023

Study Completion Date

November 13, 2024

Conditions
Metastatic Intracranial Malignant NeoplasmRecurrent Intracranial Neoplasm
Interventions
RADIATION

Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography

Undergo PET-MRI imaging

OTHER

Fluciclovine F18

Given IV

Trial Locations (1)

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

lead

Mayo Clinic

OTHER